Evolution of hypervirulence in carbapenem-resistant Klebsiella pneumoniae in China: a multicentre, molecular epidemiological analysis
Yawei Zhang(Peking University), Jing Yuan(Capital Institute of Pediatrics), Hua Gao(Peking University), Hui Wang(Peking University), Shifu Wang(South China University of Technology), Yan Jin(Second Affiliated Hospital of Xi'an Jiaotong University), Qiaozhen Cui, Longyang Jin(Peking University), Yuanyuan Xu, Cuimei Zou(Yinchuan First People's Hospital), Yumei Zhang(Peking University), Zhiwu Liu(First Hospital of Lanzhou University), Fengyan Pei(Jinan Central Hospital), Hainan Wen(Chengde Medical University), Ping Ji(UCLA Medical Center), Jinjing Tian(Fourth People's Hospital of Liaocheng), Chunlei Wang, Liang Jin(Jiangxi Academy of Sciences), Liangyi Xie(Hunan Provincial People's Hospital), Zhenpeng Li(Princeton University), Bing Gu(Westlake University), Wei Li(Harbin Medical University), Qi Wang(Peking University), Juan Wang(South China Agricultural University), Xiaoqian Zhang, Yang Li(Kunming Institute of Zoology), Xiaojuan Wang(Peking University), Xianghong Jia(Xuchang University), Quan Fu(Yunnan University), Bin Cao(Shandong Provincial Hospital), Jiaming Huang(Institut Català d'Investigació Química), Ruobing Wang(Peking University People's Hospital), Zhusheng Guo, Xiaoling Ma, Kang Liao(Nanyang Technological University), Ji Zeng(Huazhong University of Science and Technology), Rui Zheng(Ocean University of China), Chunxia Yang(Capital Medical University), Dawen Guo, Xichi Xu, Chunmei Jin(Yanbian University), Zhijie Zhang(South China University of Technology), Weiqing Wu(ShenZhen People’s Hospital), Xiaobo Ma(First Affiliated Hospital of Xiamen University), Pengwen Ouyang(Hunan Provincial People's Hospital), Haiquan Kang(Xuzhou Medical College), Hong Zou, Sijin Man(Tengzhou Central People's Hospital)
Cited by 239
Related Papers
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
|The Lancet|2020|51.8k
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
|The Lancet|2020|29.1k
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
|New England Journal of Medicine|2020|5.5k